|
Synonyms: BRII-693 | F365 | QPX9003
Comment: Soralimixin is a lipopeptide with activity against Gram-negative bacteria. It is a polymyxin analogue, rationally designed to overcome the clinical limitations of this class of antibacterial compounds [ 1]. Structure match for the INN soralimixin is included in WHO proposed list 134 (Feb 2026).
|
|
2D Structure
|
|
SMILES / InChI / InChIKey
|
|
|
Canonical SMILES
|
CC[C@H]1C(=O)N[C@@H](CCN)C(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC[C@@H](C(=O)N[C@@H](CCN)C(=O)N[C@H](CC(C)C)C(=O)N1)NC(=O)[C@H](CN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)C2=CC=C(C=C2Cl)Cl
|
|
Isomeric SMILES
|
CC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CC(C)C)CCN)NC(=O)[C@H](CN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)C2=C(C=C(C=C2)Cl)Cl)[C@@H](C)O)CCN)CCN
|
|
InChI
|
InChI=1S/C48H80Cl2N16O13/c1-6-28-39(70)59-29(9-14-51)40(71)61-32(12-17-54)44(75)65-36(23(4)67)47(78)56-18-13-33(42(73)60-30(10-15-52)41(72)63-34(19-22(2)3)45(76)57-28)62-46(77)35(21-55)64-48(79)37(24(5)68)66-43(74)31(11-16-53)58-38(69)26-8-7-25(49)20-27(26)50/h7-8,20,22-24,28-37,67-68H,6,9-19,21,51-55H2,1-5H3,(H,56,78)(H,57,76)(H,58,69)(H,59,70)(H,60,73)(H,61,71)(H,62,77)(H,63,72)(H,64,79)(H,65,75)(H,66,74)/t23-,24-,28+,29+,30+,31+,32+,33+,34-,35+,36+,37+/m1/s1
|
|
InChI Key
|
XRXBRIQKVLXFMJ-BCLXPCSMSA-N
|
Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
|
|